Despite the high expression of CD204+TAMs with low CD4+TILs expression in 20 IDH1wildtype glioblastomas compared with 7 IDH1mutant glioblastomas, this did not reach statistical significance (p = 0.779) (Table 6). The gene discussed is MSR1; the disease is glioblastoma.